Polymer-augmented liposomes enhancing antibiotic delivery against intracellular infections

Biomaterials Science
Fang-Yi SuPatrick S Stayton

Abstract

Pulmonary intracellular infections, such as tuberculosis, anthrax, and tularemia, have remained a significant challenge to conventional antibiotic therapy. Ineffective antibiotic treatment of these infections can lead not only to undesired side effects, but also to the emergence of antibiotic resistance. Aminoglycosides (e.g., streptomycin) have long been part of the therapeutic regiment for many pulmonary intracellular infections. Their bioavailability for intracellular bacterial pools, however, is limited by poor membrane permeability and rapid elimination. To address this challenge, polymer-augmented liposomes (PALs) were developed to provide improved cytosolic delivery of streptomycin to alveolar macrophages, an important host cell for intracellular pathogens. A multifunctional diblock copolymer was engineered to functionalize PALs with carbohydrate-mediated targeting, pH-responsive drug release, and endosomal release activity with a single functional polymer that replaces the pegylated lipid component to simplify the liposome formulation. The pH-sensing functionality enabled PALs to provide enhanced release of streptomycin under endosomal pH conditions (70% release in 6 hours) with limited release at physiological pH 7.4 (...Continue Reading

References

Jul 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·S Ohkuma, B Poole
May 1, 1979·Clinical Pharmacokinetics·J C Pechere, R Dugal
Nov 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G R Donowitz
Jan 1, 1993·Annual Review of Immunology·S H Kaufmann
Oct 3, 1998·Antimicrobial Agents and Chemotherapy·P LutwycheB B Finlay
Sep 2, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·N MurthyA S Hoffman
Jun 21, 2001·JAMA : the Journal of the American Medical Association·D T DennisUNKNOWN Working Group on Civilian Biodefense
Oct 5, 2002·Clinical Microbiology Reviews·Jill EllisRichard W Titball
Jul 2, 2003·Journal of Biochemical and Biophysical Methods·Cécile Grabielle-MadelmontMichel Ollivon
Oct 22, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jonathan P WongLawrence N Schofield
Dec 31, 2003·International Journal of Pharmaceutics·S P VyasParamjit Singh
Jan 9, 2004·Infectious Disease Clinics of North America·Stéphane CarrynPaul M Tulkens
Oct 6, 2004·Journal of Liposome Research·Pasquale StanoPier Luigi Luisi
Nov 20, 2004·Nature Reviews. Microbiology·Petra C F OystonRichard W Titball
Nov 27, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Wassana WijagkanalanMitsuru Hashida
Nov 1, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Anthony J ConvertinePatrick S Stayton
Apr 17, 2009·Nature Reviews. Microbiology·Katrina RayChristoph M Tang
Apr 17, 2009·Nature Reviews. Microbiology·Ronald S FlannaganSergio Grinstein
Jan 15, 2010·Methods in Molecular Biology·Nicolas BertrandJean-Christophe Leroux
Apr 24, 2010·Journal of Health, Population, and Nutrition·K Zaman
Aug 14, 2010·Microbiology·Cecilia JernbergJanet K Jansson
Oct 5, 2010·Annual Review of Pharmacology and Toxicology·Debra L LaskinJeffrey D Laskin
Dec 16, 2011·Biomaterials·Matthew J ManganielloPatrick S Stayton
Jan 15, 2013·Colloids and Surfaces. B, Biointerfaces·Luisa Di MarzioMaria Carafa
Mar 23, 2013·Luminescence : the Journal of Biological and Chemical Luminescence·Serife Evrim Kepekci TekkeliA Olcay Sağırlı
Nov 30, 2013·Angewandte Chemie·Vitaly V KomnatnyyThomas E Nielsen
Jan 22, 2014·Nature Reviews. Immunology·Tracy Hussell, Thomas J Bell
Mar 19, 2014·Antimicrobial Agents and Chemotherapy·Karleigh A HamblinHelen S Atkins
Apr 2, 2014·Infection and Immunity·Lydia M RobertsJeffrey A Frelinger
Apr 5, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Salka KellerPatrick S Stayton
Apr 22, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Amit SinghMansoor Amiji
Jan 23, 2015·World Journal of Clinical Cases·Ajay Kumar Goel
Jun 23, 2015·Polymer Chemistry·D D LaneA J Convertine
Mar 5, 2016·Pharmaceutics·David CipollaIgor Gonda
May 18, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Jasmin ChenDaniel M Ratner
May 12, 2017·PLoS Neglected Tropical Diseases·Ramar Perumal SamyLina H K Lim

❮ Previous
Next ❯

Citations

Oct 13, 2018·Drug Development Research·Marko JukičMatej Sova
Apr 21, 2019·Medicinal Research Reviews·Thanh-Nhat PhamPascal Sonnet
Aug 19, 2020·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Nikita DevnarainThirumala Govender
Oct 1, 2020·Biomaterials Science·Shuting WangJian Ji
Jul 18, 2020·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Eduardo H S SousaJosé J G Moura
Feb 14, 2021·Materials Science & Engineering. C, Materials for Biological Applications·Clara I ColinoCarmen Gutierrez-Millan
Aug 14, 2018·Journal of Controlled Release : Official Journal of the Controlled Release Society·Fang-Yi SuPatrick S Stayton
Oct 20, 2020·ACS Infectious Diseases·Elaine LimquecoDaniel M Ratner
May 29, 2021·Frontiers in Chemistry·Dongyoon KimChristoph Rademacher
Jul 3, 2021·International Journal of Molecular Sciences·Giulia Della PelleNina Kostevšek
Sep 1, 2021·Advanced Drug Delivery Reviews·Santhni SubramaniamClive A Prestidge
Oct 14, 2021·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Nawras OsmanThirumala Govender

❮ Previous
Next ❯

Methods Mentioned

BETA
size exclusion chromatography
red
gel filtration
flow
fluorescence microscopy
dynamic light scattering
Fluorescence
dynamic dialysis

Software Mentioned

FlowJo

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.